Nippon India Arbitrage Fund Regular IDCW
NAV ₹14.9534 on 13 November 2026
AMFI name: NIPPON INDIA ARBITRAGE FUND - MONTHLY IDCW Option · Scheme code 128820
IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | Category median |
|---|---|---|
| 1M | +0.51% | +0.51% |
| 6M | +2.86% | +2.77% |
| 1Y | +5.94% | +5.93% |
| 3Y | +6.53% | +6.48% |
| 5Y | +6.09% | +6.06% |
Category median: the middle return among Regular plans (Growth option) in AMFI's “Hybrid Scheme - Arbitrage Fund” category, up to 23 funds with clean data. Ranks are under “Rank among peers”.
Rank among peers
Regular plans, Growth option, in AMFI's “Hybrid Scheme - Arbitrage Fund” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Invesco Mutual Fund | +7.43% | +6.80% | 1.29 | 0.37% | ₹30,062 Cr |
| #2 | Kotak Mahindra Mutual Fund | +7.41% | +6.71% | 1.26 | 2.31% | ₹74,963 Cr |
| #2 | Tata Mutual Fund | +7.41% | +6.73% | 1.36 | 1.61% | ₹24,691 Cr |
| #4 | Aditya Birla Sun Life Mutual Fund | +7.38% | +6.67% | 1.27 | 0.27% | ₹27,071 Cr |
| #5 | Edelweiss Mutual Fund | +7.37% | +6.63% | 1.27 | - | ₹14,904 Cr |
| #6 | Mirae Asset Mutual Fund | +7.31% | +6.66% | 1.10 | 2.57% | ₹3,788 Cr |
| #7 | Axis Mutual Fund | +7.29% | +6.64% | 1.21 | 1.40% | ₹10,422 Cr |
| #8 | UTI Mutual Fund | +7.28% | +6.54% | 1.21 | 1.26% | ₹11,249 Cr |
| #- | Nippon India Arbitrage FundCurrent Fund Nippon India Mutual Fund | +6.53% | +5.94% | - | 1.34% | ₹17,157 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 1.34% · Regular 2.03%
- Exit load
- 0.25% if redeemed or switched out on or before completion of 15 days from the date of allotment of units. Nil, thereafter.
- Fund size (all plans)
- ₹17,157 CrAverage, quarter to September 2026
- Allotment date
- 14 October 2010Scheme document
- Type
- An open ended scheme investing in arbitrage opportunities. No investment in InvITs is permitted.
- AMFI scheme code
- 128820
Fund managers (3)
- Vikash Agarwal
- Rohit Hashmukh Shah
- Nemish Sheth
How each manager has done since taking over: fund manager scorecard.
Investment objective
The investment objective of the scheme is to generate income by taking advantage of the arbitrage opportunities that potentially exists between cash and derivative market and within the derivative segment along with investments in debt securities & money market instruments. There is no assurance that the investment objective of the Scheme will be achieved
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.
About this fund
Nippon India Arbitrage Fund Regular IDCW is a mutual fund scheme from Nippon India Mutual Fund, listed by AMFI under “Hybrid Scheme - Arbitrage Fund”. This page covers the Regular plan with the IDCW option. Its NAV was ₹14.9534 on 13 November 2026. Its NAV changed by 5.94% over 1 year, 6.53% a year over 3 years and 6.09% a year over 5 years. These figures leave out IDCW payouts, so they understate what investors received. The fund house rates its risk as “Low” on the SEBI riskometer. Its average assets under management were ₹17,157 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 2.03% a year for the Regular plan. Managed by Vikash Agarwal, Rohit Hashmukh Shah and Nemish Sheth. Its scheme summary document gives the allotment date as 14 October 2010.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.